New York Oncology Hematology is planning to open a new $20 million cancer center in Clifton Park, slated to be the largest cancer facility in southern Saratoga County.
The Capital Region’s largest cancer care provider announced Tuesday that it is looking to build the center at the corner of Crossing Boulevard and Sitterly Road.
“In response to our existing patients, as well as expected population growth, we recognized the need for a comprehensive cancer care in Clifton Park and are pleased to make our physicians, drug trials and genetic expertise more convenient for residents of southern Saratoga County,” said Nini Wu, president of NYOH.
Construction is scheduled to start this spring and be completed by next year. The facility requires preliminary approval from the town Planning Board. The board was expected to approve the plans in a meeting Tuesday evening.
Clifton Park town Supervisor Phil Barrett said the town is pleased to welcome another medical facility. He said the center would undoubtedly enhance health care services for local residents.
“Clifton Park has become a retail destination, and that success also attracted investments in the health care field,” Barrett said. “With Ellis Medicine and St. Peter’s also expanding here, Clifton Park is now becoming a health care destination as well.”
The 28,000-square-foot center will provide radiation oncology and medical oncology, according to NYOH. The facility will house state-of-the-art PET and CT machines, which can pinpoint the location and size of tumors for more efficient treatment.
The cancer center marks NYOH’s first facility in Clifton Park. The center is projected to cost $20 million for construction and equipment. NYOH tapped Columbia Development and BBL Construction Services for the project.
NYOH has seven offices throughout the region. The provider plans to move its Latham practice into the Clifton Park facility next year. The cancer provider is an independent, physician-owned practice.
“The Clifton Park Cancer Center is being designed for the future,” Wu said. “It will satisfy the community’s current cancer treatment needs, while giving us the capacity to meet future needs, as advances in health care and treatment come on the scene.”